Blume Capital Management’s Precigen PGEN Stock Holding History

Blume Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-250	Closed	-$6K	–	244
2017 Q2	$6K	Buy	+250	New	+$5.48K	﹤0.01%	178

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Blume Capital Management's PGEN Position: Q3 2017 in Review

Blume Capital Management sold out of Precigen (PGEN) in Q3 2017, closing a stake of 250 shares — an estimated $6K sold.

Blume Capital Management first reported a position in PGEN in Q2 2017 and held it in 1 quarter. The position peaked at $6K in Q2 2017. 155 funds tracked by Wall St. Rank hold PGEN as of Q3 2017.

Blume Capital Management reported no remaining Precigen position as of Q3 2017 after selling out during the quarter.
Blume Capital Management sold 250 Precigen shares in Q3 2017, an estimated $6K.
Blume Capital Management first reported a position in Precigen in Q2 2017 and held it in 1 quarter.
Blume Capital Management's Precigen position peaked at $6K in Q2 2017.
155 funds tracked by Wall St. Rank held Precigen as of Q3 2017.

Based on Blume Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.